Story perspectives
AI Model Personalizes Sleep Apnea Treatment, Assesses CPAP Risks
4/13/2026
1 of 1
Story summary
- Mount Sinai researchers developed an AI-powered X-ray analysis model to personalize sleep apnea treatment and estimate CPAP’s cardiovascular impact.
- The model analyzes Sleep Apnea Cardiovascular Endpoints (SAVE) trial data to identify CPAP beneficiaries and those who could be harmed.
- The study calls for careful validation of AI tools for clinical use and notes obstructive sleep apnea affects about 25 million people in the United States with higher cardiovascular risk.
